pregabalin 75 mg
1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer’s LYRICA ® (pregabalin) Capsules and Oral Solution products. However, due to Pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin is indicated for: neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) Postherpetic neuralgia (PHN) ( 1 ) Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older ( 1 ) fibromyalgia ( 1 ) neuropathic pain associated with spinal cord injury ( 1 )
Actavis Pharma, Inc.
CAPSULE ORANGE logo 2858
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
PREGABALIN capsules are available as follows: 25 mg - Each capsule with buff opaque cap and body, printed with and 2856 on both cap and body in black ink contains 25 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2856-09). 50 mg - Each capsule with ivory opaque cap and body, printed with and 2857 on both cap and body in black ink contains 50 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2857-09). 75 mg - Each capsule with orange opaque cap and ivory opaque body, printed with and 2858 on both cap and body in black ink contains 75 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2858-09). 100 mg - Each capsule with rich yellow opaque cap and ivory opaque body, printed with and 2859 on both cap and body in black ink contains 100 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2859-09). 150 mg - Each capsule with buff opaque cap and body, printed with and 2860 on both cap and body in black ink contains 150 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2860-09). 200 mg - Each capsule with rich yellow opaque cap and ivory opaque body, printed with and 2861 on both cap and body in black ink contains 200 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2861-09). 225 mg - Each capsule with orange opaque cap and ivory opaque body, printed with and 2862 on both cap and body in black ink contains 225 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2862-09). 300 mg - Each capsule with rich yellow opaque cap and buff opaque body, printed with and 2863 on both cap and body in black ink contains 300 mg of
PREGABALIN, USP. capsules are supplied in bottles of 90 (NDC 0228-2863-09). Storage and Handling Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP. 1 1 1 1 1 1 1 1
More pills like CAPSULE logo 2858